_promise-of-personalised-medicine-for-patients-with-prostate-cancer.jpg "Promise of personalised medicine for patients with prostate cancer from gu college study Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 20 min 6 sec
✓ Published: 26-Feb-2021
✓ Published: 26-Feb-2021
Description:
Dr Eleni Efstathiou (MD Anderson Cancer Center, Houston, USA), Dr Alicia Morgans (Northwestern University Feinberg School of Medicine, Chicago, USA), Prof Karim Fizazi (Institut Gustave Roussy, Villejuif, France) and Prof Gerhardt Attard (University College London, London, UK) discuss the updates from ASCO GU regarding personalised medicine for patients with prostate cancer. They initially discuss the treatment and management of patients with prostate cancer and the new data coming from ASCO GU
Dr Eleni Efstathiou (MD Anderson Cancer Center, Houston, USA), Dr Alicia Morgans (Northwestern University Feinberg School of Medicine, Chicago, USA), Prof Karim Fizazi (Institut Gustave Roussy, Villejuif, France) and Prof Gerhardt Attard (University College London, London, UK) discuss the updates from ASCO GU regarding personalised medicine for patients with prostate cancer. They initially discuss the treatment and management of patients with prostate cancer and the new data coming from ASCO GU
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_sally-gu-3921-and-the-environmental-studies-program.webp "Lehigh University College of Arts and Sciences")
_g-u-pg-entrance-2023ma-in-education-full-details.webp "MERCY SINGH")
_best-of-asco-gu-2016-prostate-cancer-data.webp "Prof Clarke (The Christie Hospital, Manchester, UK) chairs a discussion with Dr Payne (University College Hospital, London, UK) and Prof Iversen (Copenhagen Prostate Cancer Center, Copenhagen, Denmark) for ecancertv about the highlights in prostate treatment arising from ASCO GU 2016.nnThey discuss the results and implications of data coming from RTOG 0415, a randomised phase III non-inferiority study which compared two fractionation schedules in patients with low-risk prostate cancer, as well a")
_college-vlog-getting-back-into-the-grind-for-finals-at-washu-study-with-me-productive-days.webp "peachmoch")
⏲ 18 minutes 👁 498
_discover-georgetown-open-house-introduces-prospective-students-to-gu-q.webp "Georgetown University Qatar")
_5.webp "新住民花花の台灣Life")
_sally-gu-3921-and-the-environmental-studies-program.jpg)
_g-u-pg-entrance-2023ma-in-education-full-details.jpg)
_best-of-asco-gu-2016-prostate-cancer-data.jpg)
_college-vlog-getting-back-into-the-grind-for-finals-at-washu-study-with-me-productive-days.jpg)
_discover-georgetown-open-house-introduces-prospective-students-to-gu-q.jpg)
_5.jpg)
![[+]](/images/menu.gif){kind=small}